University of Minnesota Physicians
Hematology
Dr. Gregory M. Vercellotti, MD
|
|
Give Review
Gregory Vercellotti practices Hematology. He went to University of Illinois College of Medicine. He received 4 awards: "Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification", "Elected Member" and "Super Doctor". Gregory Vercellotti has written publications. He has 44 publications published with PubMed. The lastest paper is: 'Control of oxidative stress and inflammation in sickle cell disease with the Nrf2 activator dimethyl fumarate.' Gregory M. Vercellotti accepts Medicare.
Publications
- Control of oxidative stress and inflammation in sickle cell Disease with the Nrf2 activator dimethyl fumarate.
- Haptoglobin attenuates hemoglobin-induced heme oxygenase-1 in renal proximal tubule cells and kidneys of a mouse model of sickle cell Disease.
- Circulating Angiogenic Factors associated with Response and Survival in Patients with Acute Graft-versus-Host Disease: Results from Blood and Marrow Transplant Clinica...
- Reply to Eisenhut.
- High plasma erythropoietin levels are associated with prolonged coma duration and increased mortality in children with cerebral malaria.
- Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis.
- Look out heme, Mac is back in town.
- Clinical outcomes of AML patients relapsing after matched-related donor and umbilical cord blood transplantation.
- De novo CD5-positive primary cardiac diffuse large B-cell Lymphoma diagnosed by pleural fluid cytology.
- Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth.
- IL-4 Induces Up-regulation of Endothelial Cell Claudin-5 through Activation of FoxO1: Role in Protection from Complement-mediated Injury.
- Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell Disease.
- MP4CO, a pegylated hemoglobin saturated with carbon monoxide is a modulator of HO-1, inflammation and vaso-occlusion in transgenic sickle mice.
- Impact of ABO-mismatch on risk of GVHD after umbilical cord blood transplantation.
- Age sensitizes the kidney to heme protein-induced Acute kidney injury.
- Blood-Nanoparticle Interactions and in Vivo Biodistribution: Impact of Surface PEG and Ligand Properties.
- Regional and Systemic Hemodynamic Responses Following the Creation of a Murine Arteriovenous Fistula.
- Regulation of heme oxygenase-1 protein expression by miR-377 in combination with miR-217.
- Selective enhancement of contractions to α1-adrenergic receptor activation in the aorta of mice with sickle cell Disease.
- Erythroid-Specific Expression of ?-globin from Sleeping Beauty-Transduced Human Hematopoietic Progenitor Cells.
- Iron deficiency and diffuse nonscarring scalp alopecia in women: more pieces to the puzzle.
- Red Cells, hemoglobin, heme, iron, and atherogenesis.
- Early and prominent alterations in hemodynamics, signaling, and gene expression following renal ischemia in sickle cell Disease.
- The HDAC inhibitors tricHostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice.
- Inhaled carbon monoxide reduces leukocytosis in a murine model of sickle cell Disease.
- Myeloablative hematopoietic cell transplantation for Acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.
- Supression of hemin-mediated oxidation of low-density lipoprotein and subsequent endothelial reactions by hydrogen sulfide (H(2)S).
- Historical perspective and clinical implications of the Pelger-Hüet Cell.
- Quantitative real-time polymerase chain reaction (qRT-PCR) restriction fragment length polymorphism (RFLP) method for monitoring highly conserved transgene expression ...
- Tumor necrosis factor-alpha-induced accentuation in cryoinjury: mechanisms in vitro and in vivo.
- Heme, heme oxygenase, and ferritin: how the vascular endothelium survives (and dies) in an iron-rich environment.
- Robust vascular protective effect of hydroxamic acid derivatives in a sickle mouse model of inflammation.
- Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice.
- Critical role of endothelial Cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice.
- Polynitroxyl albumin inhibits inflammation and vasoocclusion in transgenic sickle mice.
- Microvascular blood flow and stasis in transgenic sickle mice: utility of a dorsal skin fold chamber for intravital microscopy.
- Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice.
- Health care economics, financing, organization, and delivery.
- Transgenic sickle mice have vascular inflammation.
- Pro-oxidant and cytotoxic effects of circulating heme.
- The Fucosylation Inhibitor, 2-Fluorofucose, Inhibits Vaso-Occlusion, Leukocyte-Endothelium Interactions and NF-ĸB Activation in Transgenic Sickle Mice.
- H-ferritin ferroxidase induces cytoprotective pathways and inhibits microvascular stasis in transgenic sickle mice.
- β-Globin Sleeping Beauty Transposon Reduces Red Blood Cell Sickling in a Patient-Derived CD34(+)-Based In Vitro Model.
Schools
University Of Illinois College Of Medicine Chicago
Wisc Hospital
Minn
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- HPC Transplantation (Stem Cell Transplant)
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Bladder Cancer
- View All
Doctors Specialties
- Hematology
- Oncology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Elected Member
- Super Doctor
Education
-
University of Minnesota at Fairview -
University of Wisconsin -
University of Illinois College of Medicine
Hospital
-
University of Minnesota Medical Center, Fairview
Drug Facts
| NPI NUMBER | 1912008921 | |
| NPPES Provider LastName | VERCELLOTTI | |
| NPPES Provider FirstName | GREGORY | |
| NPPES Provider ZIPCode | 55455 | |
| NPPES Provider State | MN | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 489.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1912008921 |
| Last Name Of The Provider | VERCELLOTTI |
| First Name Of The Provider | GREGORY |
| View All |
Similar Doctors
|
|
Dr. Gary L. Grammens, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. R David Dexter, MD |
|
|
Dr. Hector A. Mesa-Corrales, MD |
|
|
Dr. Rajini K. Malisetti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Navneet S. Majhail, MD |
|
|
Dr. Robert T. Perri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kendra L. Kubiak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dylan M. Zylla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wesley J. Miller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zohar Sachs, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chung M. Lee, MD |
|
|
Dr. John C. Manion, MD
This Doctor is OpenDoctor Recommended.
|